November 4, 2003
Source: The Press,
4
November 2003 via
Life Sciences Network
Report concludes onions pose 'negligible risk'
The first day of a public hearing on field trials of genetically
modified (GM) onions went into a secret session yesterday after
it emerged the Government-funded researchers had a mystery US
collaborator.
The hearing was called by the Environmental Risk Management
Authority (Erma), to consider the first application in three
years for a GM field trial.
Lincoln Crop and Food researcher Dr Colin Eady has applied to
trial onions resistant to the herbicide glyphosate (found in
Roundup).
It attracted a record 1900 written submissions, 41 to be made
orally at the hearing in
Christchurch.
In opening the three-day hearing, chairman Colin Mantell warned
that many submitters raised issues beyond the application's
scope.
The application was for a small field trial – less than 15m
square – and the hearing could not consider issues relating to
the release or commercialisation of a GM crop.
Many in the small audience of scientists and anti-GM lobbyists
were then stunned to hear Crop and Food lawyer Michael Garbett
say details of a research collaborator must remain confidential.
Further, he said, the collaborator would be carrying out the
trials, but its research results would also be kept
confidential.
Susie Lees, of GE Free New Zealand, said secrecy was pointless
when an Internet search made it clear it was international seed
company Seminis.
Both Crop and Food and Seminis are applying for patents related
to the transformation of onions using agrobacterium.
Dr Eady refused to comment.
Outside the hearing, Greenpeace pointed out Dr Eady had
co-authored a scientific paper on his herbicide-resistant onion
which acknowledged the help of Monsanto, a US biotechology firm
which is the world leader in GM crops and manufacturers of
Roundup.
Greenpeace spokesman Steve Abel said New Zealand taxpayers were
part-funding the research and bearing the potential risks yet
the benefits could be going overseas.
Despite this, the four-member Erma panel went into a closed
session to discuss the commercial funding, the patent
application, the potential value of the GM onion seeds and their
potential cost, and to confirm that Crop and Food had public
liability insurance.
In the face of rigorous questioning from biologist and Erma
member Dr Lin Roberts, during the open part of the hearing, Dr
Eady insisted the GM onions could benefit the environment by
dramatically cutting the use of chemicals.
Onion consultant Richard Wood, appointed by Erma, said Dr Eady's
application overstated the likely reduction in sprays and costs
and underestimated the chemicals needed to grow his GM onion.
He said GM onions did have the potential to cut herbicide usage
by up to 50 per cent.
In a 163-page report, Erma staff concluded the trial posed a
"negligible risk" to people, animals, and the environment.
They concluded it was "highly improbable" the onion plants would
flower in the field, as plants could be readily spotted and
removed weeks before any flower developed.
Erma further concluded there was a "negligible risk" of gene
transfer to weeds and an "insignificant risk" of transfer to
other crops.
They questioned whether there was any benefit in the research
for the wider community and that Crop and Food had been "unable
to verify" claims the trial would provide information on
environmental effects.
Lincoln
University organics expert Dr Tim Jenkins said that, as United
States trials were being conducted, there was no need to do them
in New Zealand.
He added that the amount of organic onion produced in New
Zealand was small but "growing steadily" and, due to its high
margins, was a "significant income earner" for growers. |